EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Scworx Corp (WORX) fair value: what the stock is really worth

We calculate from audited financials what Scworx Corp is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily.

  1. Price below fair value? Yes
  2. Good quality? No
  3. Add to watchlist

Healthcare · US · ISIN US78396V1098

SC Scworx Corp logo

Scworx Corp

WORX · US
Evidence: Low As of: Sep 12, 2026
Price$3.00
Fair Value$5.25
Upside+75.1%
Quality27/100

Cheap, value-trap riskThe stock looks deeply undervalued, but low quality raises value-trap risk.

Fair value $5.25 · Strongly undervalued (+75%)
!Quality 27/100 (market factors 9, not scored)
!Weak Growth (revenue 5y −11.2 %/yr)
!Loss-making · -142.7% net margin (TTM)
!Low debt · negative free cash flow
!Mixed vs. peers (4/10)
!Narrow moat 8/100
!Evidence only low, so the estimate is less certain
!Weak on future: 17 out of 100

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$10,314 $3.00 Fair Value $5.25 May 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 12, 2026.

How to read this chart

60‑month range $3.00 – $10,314 · fair‑value band $4.03 – $6.48 · the $3.00 price screens below the $5.25 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 12, 2026.

Which stocks are undervalued right now? Check free Discover now →

Company profile

SCWorx Corp., together with its subsidiaries, provides data content and services related to the repair, normalization and interoperability of information for healthcare providers in the United States.

Show more

SCWorx Corp., together with its subsidiaries, provides data content and services related to the repair, normalization and interoperability of information for healthcare providers in the United States. The company develops and markets healthcare information technology solutions and associated services that improve healthcare processes and information flow within hospitals and other healthcare facilities. Its software modules perform separate functions; electronic medical record management; charge description master management; contract management; request for proposal automation; integration of acquired businesses; rebate management; big data analytics model; and data integration and warehousing. The company sells its solutions and services to hospitals and health systems through a direct sales force, and distribution and reseller partnerships. SCWorx Corp. is based in Middleton, Massachusetts.

Stock analysis

Scworx Corp (WORX) currently trades at $3.00, while our model-based Fair Value estimate is $5.25, implying the stock looks roughly 42.9% undervalued today.

Show more

Valuation

Bull case: the Multiples group reads highest at a median of $5.25 per share, and 3 of the 4 models we run sit above the $3.00 price.

Bear case: the Asset-Based group reads lowest at $1.02, and 1 of the 4 models stay below the price. Evidence for this calculation is low.

Scenario range: $4.03 (bear) to $6.48 (bull), the price of $3.00 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 27/100 (below-average quality), in the Healthcare sector.

Weak Growth: Revenue growth is weak, negative or inconsistent.

Scworx Corp reported revenue of $2.9M in FY2025 versus $4.6M in FY2021, a compound −11.2%/yr. Reported net income was −$4.4M in FY2025.

Key figures

Market cap $640K · P/S ratio 0.22 · EPS (TTM) $−5.60 · Net margin −143% · Return on equity −65.5% · Return on assets (EBIT) −24.0% · Operating margin −18.2% · Revenue (TTM) $2.9M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 32 out of 100 (low confidence).

What moves the price

The share trades about 59% below its 52-week high, currently above its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −67% fair-value upside, at 75%, WORX screens cheaper than that median.

Fair Value models

Model Each model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence Evidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
EV/EBITDA $4.03 $5.25 $6.48 67
Gordon GGM $2.54 $4.24 $5.51 66
DDM Multi-Stage $2.54 $4.03 $4.57 65
All 4 models by family
Dividend Discount
Gordon GGM $2.54 $4.24 $5.51 66
DDM Multi-Stage $2.54 $4.03 $4.57 65
Multiples
EV/EBITDA $4.03 $5.25 $6.48 67
Asset-Based
NCAV (Graham) $0.7624 $1.02 $1.52 54

Open the full fair value analysis

Notify me when WORX reaches fair value

Put WORX on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Free, no payment details. Unsubscribe anytime in one click.

Key figures & financial health

Market cap $640K
P/S ratio 0.22 TTM
EPS (TTM) $−5.60
Net margin −143% TTM
Return on equity −65.5% TTM
Return on assets (EBIT) −24.0% avg 5y
More key figures
Profitability
Operating margin −18.2% TTM
Growth
Revenue (TTM) $2.9M TTM
Revenue growth (YoY) +3.4% 3y avg −10.7%
Balance sheet & cash flow
Free cash flow −$1.6M FY2025
Net cash $1.6M FY2025

Quality Score breakdown

Overall quality 27/100

Of which business quality 29 · Market factors (momentum, volatility) 9

Profitability 8
Margins and returns on capital today
Quality Growth 21
Are margins and returns improving?
Cashflow 0
Earnings quality: real cash, not paper profit
Fin. Strength 67
Balance sheet, leverage, solvency risk
Investment 97
Disciplined investing over empire-building
Low Volatility 8
Calm price path (market factor)
Momentum 3
Price trend over the last 3–12 months (market factor)
52W Momentum 19
Distance to the 52-week high (market factor)
Net Issuance 0
Buybacks instead of dilution

Open the full quality analysis

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Scworx Corp reported revenue of $2.9M in FY2025 versus $4.6M in FY2021, a compound −11.2%/yr. Reported net income was −$4.4M in FY2025.

Growth Quality Growth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 0/100
Revenue growth is weak, negative or inconsistent.
Latest Revenue (FY 2025)
$2.9M
Latest YoY
−3.7%
Avg. revenue growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−10.7%
Avg. revenue growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−11.2%
Avg. revenue growth/yr (9Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+19.2%
EBIT margin (trend) Operating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−116.0% (2020) → −33.3% (2025)
Value creation/yr We only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed
Revenue −11.2%/yr
FY21 $4.6M
FY22 $4.0M
FY23 $3.8M
FY24 $3.0M
FY25 $2.9M
Net income
FY21 −$3.8M
FY22 −$1.8M
FY23 −$4.0M
FY24 −$1.1M
FY25 −$4.4M

Watch WORX, get fair value alerts →

Share or link this analysis
𝕏 Post WhatsApp LinkedIn Reddit
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Scworx Corp Fair Value". https://www.fairvalue-calculator.com/stock/WORX

Peer Group

Health Information Services · 131 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Valuation
Quality Score 27 · Bottom 25%
Fair Value upside +66% · Top 25%
Profitability
Return on assets −6% · Below median
Net margin (TTM) −143% · Bottom 25%
Operating margin (TTM) −18% · Bottom 25%
Growth and dividend
Revenue growth 3% · Below median
Balance sheet
Debt / equity 0.00× · Below median

Valuation Multiples vs Health Information Services median · lower = cheaper

P/B 0.09× · Cheapest 25%
P/S (TTM) 0.22× · Cheapest 25%

Context: sector, industry, market

Strength profile in five axes (Snowflake)

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE100 · sector 0
FUTURE17 · sector 29
PAST0 · sector 6
HEALTH100 · sector 98
DIVIDEND0 · sector 42

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Health Information Services stocks, each showing price versus our Fair Value estimate (as of Sep 12, 2026).

Stock Price Fair Value vs Fair Value
Veeva Systems Inc VEEV $275.09 $91.49 −67%
Pro Medicus Limited PME A$183.71 A$23.74 −87%
BrightSpring Health Services, Inc BTSG $57.88 $21.31 −63%
HealthEquity, Inc HQY $104.27 $56.63 −46%
Hinge Health, Inc HNGE $92.37 $24.03 −74%
10x Genomics, Inc TXG $55.63 $17.18 −69%
Waystar Holding WAY $25.76 $12.86 −50%
XtalPi Holdings 2228 HK$7.27 HK$1.44 −80%
Doximity, Inc DOCS $26.35 $25.91 −2%
Privia Health Group PRVA $21.07 $5.26 −75%

Compare Scworx Corp with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Frequently asked questions

Is Scworx Corp (WORX) overvalued or undervalued?
As of Sep 12, 2026, our model estimates a fair value of $5.25 versus a price of $3.00, about +75% upside (undervalued).
What is the fair value of WORX?
Our model-based fair value for Scworx Corp is $5.25 (as of Sep 12, 2026), built from audited fundamentals. The current price: $3.00.
What is the quality score of WORX?
Scworx Corp has a Quality Score of 27/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Scworx Corp (WORX)?
Our model-based price target is the fair value of $5.25 (as of Sep 12, 2026) from 4 valuation models. Cautious scenario $4.03, optimistic scenario $6.48. It is a calculation from audited fundamentals, not an analyst target.
What is the Scworx Corp stock forecast for 2026?
Our models put fair value at $5.25, about +75% upside versus a price of $3.00 (undervalued). Cautious scenario $4.03, optimistic scenario $6.48. The calculation is refreshed regularly with new filings.
What is the revenue of Scworx Corp (WORX)?
Scworx Corp reported trailing-twelve-month revenue of about $2.9M (latest available figure, as of Sep 12, 2026).
What is the net profit margin of WORX?
The net profit margin of Scworx Corp is about −142.7%, meaning it is currently running at a net loss. Based on the latest reported figures.
What is the intrinsic value of Scworx Corp (WORX)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Scworx Corp it is $5.25 per share (as of Sep 12, 2026), against a price of $3.00. It is the blended result of 4 valuation models (cash flow, earnings, asset, dividend).
Is Scworx Corp stock overvalued or undervalued in 2026?
As of Sep 12, 2026, WORX trades below its calculated fair value: price $3.00, fair value $5.25, a gap of about +75% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of WORX?
No. The price is what the market pays today ($3.00); the fair value is what the company's own numbers justify ($5.25). For Scworx Corp the two are $2.25 per share apart. That gap is exactly why we show both numbers side by side.
How much is Scworx Corp worth?
The market values Scworx Corp at about $640K (market capitalisation, as of Sep 12, 2026). Per share that is $3.00; our models calculate a fair value of $5.25 per share.
What do the bullish and bearish scenarios say about WORX?
Our models span a range for Scworx Corp: cautious scenario $4.03, base $5.25, optimistic $6.48 per share (as of Sep 12, 2026, price $3.00). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Scworx Corp (WORX)?
Balance-sheet figures for Scworx Corp (as of Sep 12, 2026): return on equity −65.5%, debt of 0.00 per unit of equity. They feed the Quality Score of 27/100, which measures business quality independently of the share price.
How far is WORX from its 52-week high?
Scworx Corp trades at $3.00, about 59% below its 52-week high of $7.35 and 1,054% above the low of $0.2600 (as of Sep 12, 2026). Distance from the high says nothing about value: that is what the fair value of $5.25 is for.
Which stocks are comparable to Scworx Corp?
From the same area (Healthcare) we also value Veeva Systems Inc, Pro Medicus Limited, BrightSpring Health Services, Inc, HealthEquity, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Scworx Corp stock attractive at the current price?
The data as of Sep 12, 2026: price $3.00, calculated fair value $5.25 (+75%), Quality Score 27/100, from 4 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of WORX calculated?
We run Scworx Corp through 4 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $5.25, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 31.6 % above its aggregate fair value. Scworx Corp currently trades 75 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on <a href="/is-it-worth-investing-now/">is it worth investing now</a>.
What should I pay attention to with Scworx Corp right now?
The large discount to fair value meets weak quality (27/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case ($4.03). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Free · no account needed

Watch Scworx Corp in the live analysis

One click puts Scworx Corp on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.